Pacira BioSciences, Inc. PCRX Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s common stock, shares, outstanding?
- Pacira BioSciences, Inc. (PCRX) reported common stock, shares, outstanding of $39.31M in Q1 2026.
- How has Pacira BioSciences, Inc.'s common stock, shares, outstanding changed year-over-year?
- Pacira BioSciences, Inc.'s common stock, shares, outstanding decreased by 15.1% year-over-year, from $46.28M to $39.31M.
- What is the long-term trend for Pacira BioSciences, Inc.'s common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s common stock, shares, outstanding has grown at a -1.2% compound annual growth rate (CAGR), from $43.64M to $41.12M.